rs822336 as a predictive biomarker for anti-PD-1/PD-L1 immunotherapy in advanced NSCLC: Unraveling molecular mechanisms

被引：0
|
作者：
Polcaro, Giovanna
Liguori, Luigi
Manzo, Valentina
Chianese, Annalisa
Donadio, Giuliana
Caputo, Alessandro
Scognamiglio, Giosue
Dell'Annunziata, Federica
Langella, Maddalena
Corbi, Graziamaria
Ottaiano, Alessandro
Cascella, Marco
Perri, Francesco
De Marco, Margot
Dal Col, Jessica
Pagliara, Valentina
Zeppa, Pio
Filippelli, Amelia
Franci, Gianluigi
Dal Piaz, Fabrizio
Conti, Valeria
Pepe, Stefano
Sabbatino, Francesco
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-2531
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2531
引用
收藏
页数：2
相关论文
共 50 条
  • [1] rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC
    Polcaro, Giovanna
    Liguori, Luigi
    Manzo, Valentina
    Chianese, Annalisa
    Donadio, Giuliana
    Caputo, Alessandro
    Scognamiglio, Giosue
    Dell'Annunziata, Federica
    Langella, Maddalena
    Corbi, Graziamaria
    Ottaiano, Alessandro
    Cascella, Marco
    Perri, Francesco
    De Marco, Margot
    Dal Col, Jessica
    Nassa, Giovanni
    Giurato, Giorgio
    Zeppa, Pio
    Filippelli, Amelia
    Franci, Gianluigi
    Dal Piaz, Fabrizio
    Conti, Valeria
    Pepe, Stefano
    Sabbatino, Francesco
    [J]. MOLECULAR CANCER, 2024, 23 (01)
  • [2] rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC
    Giovanna Polcaro
    Luigi Liguori
    Valentina Manzo
    Annalisa Chianese
    Giuliana Donadio
    Alessandro Caputo
    Giosuè Scognamiglio
    Federica Dell’Annunziata
    Maddalena Langella
    Graziamaria Corbi
    Alessandro Ottaiano
    Marco Cascella
    Francesco Perri
    Margot De Marco
    Jessica Dal Col
    Giovanni Nassa
    Giorgio Giurato
    Pio Zeppa
    Amelia Filippelli
    Gianluigi Franci
    Fabrizio Dal Piaz
    Valeria Conti
    Stefano Pepe
    Francesco Sabbatino
    [J]. Molecular Cancer, 23
  • [3] Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC
    Bie, Fenglong
    Tian, He
    Sun, Nan
    Zang, Ruochuan
    Zhang, Moyan
    Song, Peng
    Liu, Lei
    Peng, Yue
    Bai, Guangyu
    Zhou, Bolun
    Gao, Shugeng
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
    Niu, Mengke
    Yi, Ming
    Li, Ning
    Luo, Suxia
    Wu, Kongming
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2021, 10 (01)
  • [5] Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
    Mengke Niu
    Ming Yi
    Ning Li
    Suxia Luo
    Kongming Wu
    [J]. Experimental Hematology & Oncology, 10
  • [6] Anti-PD-1/PD-L1 immunotherapy in conversion treatment of locally advanced hepatocellular carcinoma
    Jiaqi Chen
    Ding Zhang
    Ying Yuan
    [J]. Clinical and Experimental Medicine, 2023, 23 : 579 - 590
  • [7] Anti-PD-1/PD-L1 immunotherapy in conversion treatment of locally advanced hepatocellular carcinoma
    Chen, Jiaqi
    Zhang, Ding
    Yuan, Ying
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (03) : 579 - 590
  • [8] Inflammatory and autoimmune predictive markers of response to anti-PD-1/PD-L1 therapy in NSCLC and melanoma
    Musaelyan, Aram A. A.
    Lapin, Sergey L. V.
    Urtenova, Margarita A. A.
    Odintsova, Svetlana V. V.
    Chistyakov, Ivan V. V.
    Ulitin, Andrey M. M.
    Akopov, Andrey L. L.
    Orlov, Sergey V. V.
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 24 (03)
  • [9] Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?
    Festino, Lucia
    Botti, Gerardo
    Lorigan, Paul
    Masucci, Giuseppe V.
    Hipp, Jason D.
    Horak, Christine E.
    Melero, Ignacio
    Ascierto, Paolo A.
    [J]. DRUGS, 2016, 76 (09) : 925 - 945
  • [10] Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?
    Lucia Festino
    Gerardo Botti
    Paul Lorigan
    Giuseppe V. Masucci
    Jason D. Hipp
    Christine E. Horak
    Ignacio Melero
    Paolo A. Ascierto
    [J]. Drugs, 2016, 76 : 925 - 945
12345